ANI Pharmaceuticals
ANIP
ANIP
121 hedge funds and large institutions have $275M invested in ANI Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 35 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
32% less capital invested
Capital invested by funds: $402M → $275M (-$127M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
121
Holding in Top 10
2
Calls
$6.29M
Puts
$4.6M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$9.45M | |
| 3 | +$7.51M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.15M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.47M |
Top Sellers
| 1 | -$12.2M | |
| 2 | -$3.57M | |
| 3 | -$3.46M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.9M |
| 5 |
TA
Teachers Advisors
New York
|
-$2.5M |